or
Bookmark and Share
Esters of (+)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidi nemethanol
   
Document Number
US Patent 6063793
Issued Date
May 16, 2000
Link
Inventors
Map
Abstract
The present invention is directed to esters of (+)-.alpha.-(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidine methanol, pharmaceutical formulations, methods of making and methods of using these esters. These compounds antagonize the effects of serotonin at the 5HT.sub.2A receptor and are useful in treating various conditions such as, for example, psychoses such as schizophrenia.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
1
Comments:
no comments yet
Owner
Published
May 16, 2000
Application Number
09/337,957
Filed
June 22, 1999
US Classification
514/317   546/239
Int'l Classification
C07D   211/00   (20060101)   C07D   211/22   (20060101)  
Attorney/Law Firm
Parent Case
This application is a Divisional of 08/900,462, filed Jul. 25, 1997, now U.S. Pat. No. 6,028,083.
USPTO Field of Search
546/239   514/317  
Related Patents
7132433 - Use of (+)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4- piperidinemethanol or its prodrug in the treatment of behavioral or psychological symptoms associated with a disease - Owned by Aventis Pharmaceuticals Inc. (Bridgewater, NJ)

The present invention is directed to use of (+)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidin- emethanol or its prodrug depicted as Formula II, wherein R is C.sub.1-20alkyl, in treating patients for behavioral or psychological symptoms associated with Alzheimer's disease, Lewy body dementia or Parkinson's disease. ##STR00001##

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us